STAAR Surgical Company (STAA)
Automate Your Wheel Strategy on STAA
With Tiblio's Option Bot, you can configure your own wheel strategy including STAA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol STAA
- Rev/Share 4.5325
- Book/Share 6.7967
- PB 3.8232
- Debt/Equity 0.1204
- CurrentRatio 4.9435
- ROIC -0.2789
- MktCap 1287606979.0
- FreeCF/Share -0.5265
- PFCF -49.3866
- PE -13.5065
- Debt/Assets 0.0926
- DivYield 0
- ROE -0.252
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 3
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | STAA | Wells Fargo | -- | Equal Weight | -- | $17 | April 21, 2025 |
| Downgrade | STAA | BTIG Research | Buy | Neutral | -- | -- | Feb. 12, 2025 |
| Downgrade | STAA | Jefferies | Buy | Hold | -- | -- | Feb. 12, 2025 |
| Downgrade | STAA | Mizuho | Outperform | Neutral | $45 | $17 | Feb. 12, 2025 |
| Downgrade | STAA | William Blair | Outperform | Market Perform | -- | -- | Feb. 12, 2025 |
News
Broadwood Partners Comments on STAAR Surgical's Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon
Published: October 14, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the recent Current Report on Form 8-K filed by STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) with the U.S. Securities and Exchange Commission (“SEC”) of a “supplement” to the Company's definitive proxy statement, filed on September 16, 2025, in connection with the proposed acquisition of STAAR by Alcon Inc. (“Alcon”) (NYSE: ALC). Broadwood, which owns 27.5% of STAAR.
Read More
STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card
Published: October 08, 2025 by: Business Wire
Sentiment: Neutral
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today provided the following statement in response to a report issued by Glass, Lewis & Co., LLC (“Glass Lewis”) related to STAAR's pending merger with Alcon (SIX/NYSE: ALC): The STAAR Board of Directors and management team strongly disagree with the recommendation issued by Glass Lewis.
Read More
Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon
Published: October 07, 2025 by: PRNewsWire
Sentiment: Neutral
CHARLOTTE, N.C. , Oct. 7, 2025 /PRNewswire/ -- Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) owning approximately 1.5% of the Company's outstanding common stock, today issued the following statement outlining its opposition of the proposed acquisition of STAAR by Alcon Inc. ("Alcon") (NYSE: ALC): We have been significant STAAR shareholders for more than ten years and remain convicted in the significant value of the Company.
Read More
Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical
Published: October 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP continues its investigation into whether the board members of STAAR Surgical Company (NASDAQ: STAA) breached their fiduciary duties in connection with the proposed sale of the Company to Alcon (NYSE: ALC).
Read More
Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical's Sale to Alcon
Published: October 03, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today announced that it has published a presentation outlining why stockholders should vote on Broadwood's GREEN Proxy Card “AGAINST” the proposed acquisition of the Company by an affiliate of Alcon Inc. (NYSE: ALC) on the terms announced on August 5, 2025. The 81-pa.
Read More
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon's Acquisition of STAAR
Published: September 30, 2025 by: Business Wire
Sentiment: Neutral
GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the manufacturer of the Implantable Collamer® Lens (ICL), today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR), in connection with Alcon's acquisition of STAAR, expired at 11:59 p.m. ET on September 29, 2025. As previously announced,.
Read More
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA and CYBR on Behalf of Shareholders
Published: September 29, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Sept. 29, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: STAAR Surgical Company (NASDAQ: STAA)'s sale to Alcon for $28.00 per share in cash.
Read More
STAAR SHAREHOLDER ALERT: Kaskela Law LLC Investigates Fairness of Proposed STAAR Surgical Company (NASDAQ: STAA) Shareholder Buyout and Encourages Investors to Contact the Firm to Discuss their Legal Rights and Options
Published: September 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
PHILADELPHIA, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The law firm of Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of STAAR Surgical Company (NASDAQ: STAA) (“STAAR” or the “Company”) shareholders to determine whether the proposal is fair to investors.
Read More
STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders
Published: September 16, 2025 by: Business Wire
Sentiment: Neutral
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission in connection with the Company's pending merger with Alcon (SIX/NYSE: ALC). STAAR will hold a Special Meeting of Stockholders on October 23 at 8:30 a.m. (Pacific Time) to vote to adopt the.
Read More
Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical
Published: September 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP continues its investigation into whether the board members of STAAR Surgical Company (NASDAQ: STAA) breached their fiduciary duties in connection with the proposed sale of the Company to Alcon (NYSE: ALC).
Read More
Staar Surgical (STAA) International Revenue in Focus: Trends and Expectations
Published: August 11, 2025 by: Zacks Investment Research
Sentiment: Neutral
Examine Staar Surgical's (STAA) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Read More
Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical
Published: August 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of STAAR Surgical Company (NASDAQ: STAA) breached their fiduciary duties in connection with the proposed sale of the Company to Alcon (NYSE: ALC).
Read More
STAA Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of STAAR Surgical to Alcon
Published: August 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
MONSEY, N.Y., Aug. 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of STAAR Surgical Company (Nasdaq: STAA) (“STAAR”) to Alcon, Inc. (“Alcon”) for $28.00 per share in cash.
Read More
Shareholder Alert: The Ademi Firm investigates whether STAAR Surgical Company is obtaining a Fair Price for its Public Shareholders
Published: August 05, 2025 by: PRNewsWire
Sentiment: Neutral
MILWAUKEE , Aug. 5, 2025 /PRNewswire/ -- The Ademi Firm is investigating STAAR (NASDAQ: STAA) for possible breaches of fiduciary duty and other violations of law in its transaction with Alcon Inc. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.
Read More
STAAR Surgical Announces $30 Million Share Repurchase Authorization
Published: May 16, 2025 by: Business Wire
Sentiment: Neutral
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $30 million of its outstanding common stock. “Our decision to initiate a share repurchase program underscores the Board's and management's confidence in STAAR's future and.
Read More
STAAR Surgical Company (STAA) Q1 2025 Earnings Call Transcript
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Neutral
STAAR Surgical Company. (NASDAQ:STAA ) Q1 2025 Earnings Conference Call May 7, 2025 5:15 PM ET Company Participants Brian Moore - VP, Investor Relations and Corporate Development Stephen Farrell - Chair of the Board, President and CEO Warren Faust - President and COO Deborah Andrews - Interim CFO Conference Call Participants Tom Stephan - Stifel Anthony Petrone - Mizuho Ryan Zimmerman - BTIG Patrick Wood - Morgan Stanley Operator Greetings and welcome to the STAAR Surgical First Quarter 2025 Earnings Webcast.
Read More
Staar Surgical (STAA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Staar Surgical (STAA) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Staar Surgical (STAA) Reports Q1 Loss, Tops Revenue Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Negative
Staar Surgical (STAA) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to earnings of $0.06 per share a year ago.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company. - STAA
Published: March 19, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company. - STAA
Published: March 17, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , March 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company. - STAA
Published: March 13, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company. - STAA
Published: March 07, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
Did STAAR Surgical Company Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- STAA
Published: March 05, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / March 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of STAAR Surgical Company ("STAAR Surgical Company") (NASDAQ:STAA) concerning possible violations of federal securities laws. Staar reported disappointing earnings for Q4 2024, blaming the results on weak demand in China and a drop in refractive procedures.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company. - STAA
Published: March 05, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / March 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
An Investigation Has Commenced on Behalf of STAAR Surgical Company Shareholders. Contact Levi & Korsinsky to Discuss your STAA Losses.
Published: March 03, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of STAAR Surgical Company ("STAAR Surgical Company") (NASDAQ:STAA) concerning possible violations of federal securities laws. Staar reported disappointing earnings for Q4 2024, blaming the results on weak demand in China and a drop in refractive procedures.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company. - STAA
Published: March 03, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , March 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
STAAR Surgical Company Being Investigated on Behalf of STAAR Surgical Company Investors. Contact Levi & Korsinsky For Details
Published: February 28, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / February 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of STAAR Surgical Company ("STAAR Surgical Company") (NASDAQ:STAA) concerning possible violations of federal securities laws. Staar reported disappointing earnings for Q4 2024, blaming the results on weak demand in China and a drop in refractive procedures.
Read More
The Schall Law Firm Invites Shareholders With Losses In STAAR Surgical Company To Join A Securities Fraud Investigation
Published: February 28, 2025 by: Accesswire
Sentiment: Neutral
LOS ANGELES, CA / ACCESS Newswire / February 28, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of STAAR Surgical Company ("Staar" or "the Company") (NASDAQ:STAA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Read More
An Investigation Has Been Launched Into STAAR Surgical Company For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
Published: February 27, 2025 by: Accesswire
Sentiment: Neutral
LOS ANGELES, CA / ACCESS Newswire / February 27, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of STAAR Surgical Company ("Staar" or "the Company") (NASDAQ:STAA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Read More
STAAR Surgical Announces Leadership Transition
Published: February 26, 2025 by: Business Wire
Sentiment: Neutral
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced a leadership transition. Stephen C. Farrell, current Lead Independent Director of the STAAR Board of Directors, has been appointed President and CEO, effective February 26, 2025. Tom Frinzi, STAAR's current President and CEO, will remain with the Company in an advisory role through Janu.
Read More
About STAAR Surgical Company (STAA)
- IPO Date 1992-02-24
- Website https://www.staar.com
- Industry Medical - Instruments & Supplies
- CEO Stephen C. Farrell CFA
- Employees 1157